Table 3
Predicted five-year relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using 2000-2002 life tables to derive expected survival, by sex and age group, selected cancers, Canada excluding Quebec, 2005 to 2007

Table 3
Predicted five-year relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using 2000-2002 life tables to derive expected survival, by sex and age group, selected cancers, Canada excluding Quebec, 2005 to 2007
Table summary
This table displays the results of Predicted five-year relative survival ratios (RSR) derived using 2005-2007 life tables and positive bias introduced by using 2000-2002 life tables to derive expected survival. The information is grouped by Cancer (appearing as row headers), RSR (%) derived using 2005-2007 life tables , Positive absolute bias introduced by using 2000-2002 life tables (% units), Sex and Age group (appearing as column headers).
Cancer RSR (%) derived using 2005-2007 life tables Positive absolute bias introduced by using 2000-2002 life tables (% units)
Sex Age group Sex Age group
Male Female 15 to 54 55 to 64 65 to 74 75 to 99 Male Female 15 to 54 55 to 64 65 to 74 75 to 99
All cancers 61.3 63.2 75.8 67.6 61.5 47.9 1.2 0.5 0.1 0.4 0.8 1.9
Oral cavity and pharynx 59.7 66.5 73.2 62.3 54.6 53.5 0.8 0.5 0.1 0.4 0.8 2.2
Esophagus 13.6 15.4 17.3 15.5 17.3 9.1 0.2 0.2 0.0 0.1 0.3 0.4
Stomach 23.2 26.8 31.4 26.8 27.3 18.3 0.5 0.3 0.0 0.2 0.4 0.8
Colon excluding rectum 62.7 63.1 65.1 66.6 66.8 58.0 1.5 0.8 0.1 0.4 0.9 2.2
Rectum and rectosigmoid 62.3 64.9 68.3 68.9 63.9 55.6 1.2 0.6 0.1 0.4 0.9 2.2
Liver 19.1 18.3 29.9 22.2 16.1 8.9 0.2 0.1 0.0 0.1 0.2 0.4
Pancreas 7.0 7.7 16.2 7.8 7.0 4.9 0.1 0.1 0.0 0.0 0.1 0.2
Larynx 62.9 61.1 68.7 66.7 57.8 61.5 1.1 0.5 0.1 0.5 0.9 2.9
Lung and bronchus 13.5 19.3 22.4 19.3 16.5 11.8 0.3 0.2 0.0 0.1 0.2 0.4
Skin melanoma 85.6 91.9 92.3 89.3 86.7 81.1 1.3 0.5 0.1 0.5 1.2 3.4
Female breast ... 87.2 88.6 89.2 88.6 80.5 ... 0.6 0.1 0.3 0.6 1.8
Cervix uteri ... 72.8 79.7 65.2 59.0 43.5 ... 0.2 0.0 0.2 0.4 1.1
Corpus uteri ... 85.2 90.6 89.0 82.9 74.0 ... 0.6 0.1 0.3 0.5 1.7
Ovary ... 43.9 66.3 44.7 33.4 20.8 ... 0.2 0.1 0.2 0.2 0.5
Prostate 94.9 ... 95.6 97.7 97.9 86.5 2.0 ... 0.2 0.7 1.7 4.6
Bladder (including in situ) 72.5 66.4 82.2 80.0 74.4 61.1 1.9 0.7 0.1 0.5 1.2 2.8
Kidney and renal pelvis 66.9 68.2 79.5 70.8 66.8 51.9 1.0 0.5 0.1 0.4 0.9 2.0
Brain 20.4 25.7 44.2 13.0 9.9 3.5 0.1 0.1 0.0 0.1 0.1 0.1
Thyroid 93.9 98.8 99.4 98.0 92.8 84.4 0.6 0.2 0.1 0.4 0.9 2.3
Hodgkin lymphoma 83.4 86.5 93.5 81.3 59.1 35.3 0.3 0.2 0.0 0.5 0.7 1.2
Non-Hodgkin lymphoma 61.8 66.2 78.9 73.3 60.4 45.9 0.9 0.5 0.1 0.4 0.7 1.7
Multiple myeloma 39.3 36.4 60.3 51.0 36.2 22.8 0.8 0.4 0.1 0.3 0.5 0.9
Chronic lymphocytic leukemia 77.0 81.5 91.5 88.2 82.3 64.7 1.7 0.9 0.1 0.5 1.0 2.6
... not applicable
Source: Canadian Cancer Registry database at Statistics Canada.
Date modified: